Ignite Creation Date:
2025-12-24 @ 7:41 PM
Ignite Modification Date:
2026-04-18 @ 11:58 PM
Study NCT ID:
NCT00844103
Status:
COMPLETED
Last Update Posted:
2009-04-30
First Post:
2009-02-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of AZD8566.
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D1320C00002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Harsukh Parmar , Medical Science Director, Respiratory and Inflammation Emerging Product Team
Old Organization:
AstraZeneca Pharmaceuticals